Elanco Animal Health (ELAN) Cash from Financing Activities (2017 - 2026)

Elanco Animal Health (ELAN) has 10 years of Cash from Financing Activities data on file, last reported at -$65.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities fell 225.0% year-over-year to -$65.0 million; the trailing twelve-month figure through Mar 2026 stood at -$392.0 million (up 72.26% YoY), and the FY2025 full-year result was -$275.0 million, up 81.57% from the prior year.
• Cash from Financing Activities retreated to -$65.0 million in Q1 2026, from -$18.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $174.0 million in Q1 2023 to a low of -$1.3 billion in Q3 2024.
• A 5-year average of -$144.9 million and a median of -$93.0 million in 2024 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities plunged 10100.0% in 2022 and soared 292.59% in 2025, its largest moves.
• Tracing ELAN's Cash from Financing Activities over 5 years: stood at -$84.0 million in 2022, then slumped by 65.48% to -$139.0 million in 2023, then jumped by 76.98% to -$32.0 million in 2024, then jumped by 43.75% to -$18.0 million in 2025, then plunged by 261.11% to -$65.0 million in 2026.
• Business Quant data shows ELAN's Cash from Financing Activities at -$65.0 million in Q1 2026, -$18.0 million in Q4 2025, and -$153.0 million in Q3 2025.